imipenem, anhydrous has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camoin, L; Canaan, S; Cavalier, JF; Durand, T; Spilling, CD | 1 |
| Alam, MDS; Cai, X; Chhotaray, C; Cook, GM; Fang, C; Gao, Y; Ge, H; Guo, L; Hameed, HMA; Lin, Y; Lu, Z; Maslov, DA; Peng, J; Tian, X; Wang, S; Yu, W; Yusuf, B; Zeng, S; Zhang, B; Zhang, G; Zhang, J; Zhang, T; Zhong, N | 1 |
1 review(s) available for imipenem, anhydrous and Koch's Disease
| Article | Year |
|---|---|
Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
Topics: Antitubercular Agents; Carboxylic Ester Hydrolases; Drug Design; Enzyme Inhibitors; Humans; Lactones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Organophosphorus Compounds; Orlistat; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2021 |
1 other study(ies) available for imipenem, anhydrous and Koch's Disease
| Article | Year |
|---|---|
Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Imipenem; Linezolid; Mice; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Pentosyltransferases; Permeability; Rifabutin; Tuberculosis | 2022 |